Back
Day Range
$12.63
$13.18
52-Week Range
$5.90
$28.25
Volume
3,336,008
50D / 200D Avg
$12.99
/
$12.58
Prev Close
$13.11
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.7 | 0.3 |
| P/B | 2.3 | 2.9 |
| ROE % | -53.5 | 3.7 |
| Net Margin % | -609.9 | 3.8 |
| Rev Growth 5Y % | 19.6 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$19.38
+51.3%
Low: $7.00
High: $48.00
Forward EPS
-$3.62
Est. Revenue
59 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$8.76
-$1.79 – $99.21
|
2.5 B | 5 |
| FY2029 |
$3.86
-$0.79 – $43.72
|
1.6 B | 10 |
| FY2028 |
-$0.69
-$3.57 – $15.82
|
670 M | 12 |
Key Takeaways
Revenue grew 19.62% annually over 5 years — strong growth
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -354.66M
PEG of 0.09 suggests growth is underpriced
Capital efficient — spends only 8.54% of revenue on capex
Growth
Revenue Growth (5Y)
19.62%
Revenue (1Y)16.92%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-53.48%
ROIC-43.25%
Net Margin-609.85%
Op. Margin-651.67%
Safety
Debt / Equity
0.14
Current Ratio5.08
Interest Coverage0.00
Valuation
P/E Ratio
-3.67
P/B Ratio2.25
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.92% | Revenue Growth (3Y) | 36.58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19.62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 67.67M | Net Income (TTM) | -412.69M |
| ROE | -53.48% | ROA | -49.01% |
| Gross Margin | 76.47% | Operating Margin | -651.67% |
| Net Margin | -609.85% | Free Cash Flow (TTM) | -354.66M |
| ROIC | -43.25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 5.08 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.67 | P/B Ratio | 2.25 |
| P/S Ratio | 22.36 | PEG Ratio | 0.09 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.51B | Enterprise Value | 1.45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 67.67M | 57.88M | 36.28M | 52.12M | 33.05M |
| Net Income | -412.69M | -519.02M | -481.19M | -474.19M | -267.89M |
| EPS (Diluted) | -3.81 | -5.25 | -5.42 | -6.16 | -3.78 |
| Gross Profit | 51.75M | 47.59M | 27.30M | 44.55M | 26.16M |
| Operating Income | -440.99M | -534.26M | -515.29M | -458.16M | -267.85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 842.13M | 1.19B | 1.30B | 1.52B | 1.29B |
| Total Liabilities | 170.73M | 319.06M | 250.81M | 284.53M | 254.22M |
| Shareholders' Equity | 671.39M | 871.96M | 1.05B | 1.24B | 1.04B |
| Total Debt | 93.33M | 210.20M | 115.35M | 130.70M | 74.02M |
| Cash & Equivalents | 155.46M | 189.18M | 226.75M | 523.51M | 123.41M |
| Current Assets | 527.71M | 639.86M | 998.33M | 1.22B | 769.30M |
| Current Liabilities | 103.88M | 110.85M | 115.21M | 126.55M | 125.83M |